
Results
7
Mid-Large Cap Stocks
7 companies
Merck KGaA
Market Cap: €57.7b
Operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.
MRK
€132.05
7D
-4.4%
1Y
17.8%
Dermapharm Holding
Market Cap: €2.4b
Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.
DMP
€48.15
7D
4.0%
1Y
37.4%
SCHOTT Pharma KGaA
Market Cap: €2.6b
Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.
1SXP
€17.18
7D
-1.7%
1Y
-38.9%
Hamlet BioPharma
Market Cap: €1.3b
Engages in the development of drugs for the treatment and prevention of cancer in Sweden.
7ZT
€0.63
7D
-5.4%
1Y
n/a
Gerresheimer
Market Cap: €862.8m
Provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.
GXI
€24.46
7D
-1.0%
1Y
-43.1%
Bayer
Market Cap: €35.7b
Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
BAYN
€36.07
7D
1.6%
1Y
32.8%
Evotec
Market Cap: €868.1m
Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.
EVT
€4.70
7D
-1.1%
1Y
-32.9%